Blincyto (blinatumomab) - Amgen
Rituxan (rituximab) - Roche
cyclophosphamide - Generic mfg.
Blinatumomab as the first-line induction for ANCA-associated rapidly progressive glomerulonephritis. (PubMed, RMD Open) - Sep 24, 2026 - No abstract available 
Journal • ANCA Vasculitis • Glomerulonephritis • Nephrology • Vasculitis
http://www.ncbi.nlm.nih.gov/pubmed/42778331
 
Bisheng Shi; Fang Du; HuiHua Ding; Juan Wang; Rui Li; Sheng Chen; Shuang Ye; Wenyi Wu; Ye Yu
 
Sep 24, 2026
 
Prev Next